KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Interest & Investment Income: 2022-2024

Historic Interest & Investment Income for Neogenomics (NEO) over the last 3 years, with Dec 2024 value amounting to $18.4 million.

  • Neogenomics' Interest & Investment Income fell 66.55% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year decrease of 37.32%. This contributed to the annual value of $18.4 million for FY2024, which is 9.02% up from last year.
  • Per Neogenomics' latest filing, its Interest & Investment Income stood at $18.4 million for FY2024, which was up 9.02% from $16.9 million recorded in FY2023.
  • Neogenomics' 5-year Interest & Investment Income high stood at $18.4 million for FY2024, and its period low was $6.1 million during FY2022.
  • Over the past 3 years, Neogenomics' median Interest & Investment Income value was $16.9 million (recorded in 2023), while the average stood at $13.8 million.
  • Data for Neogenomics' Interest & Investment Income shows a peak YoY surged of 178.22% (in 2023) over the last 5 years.
  • Over the past 3 years, Neogenomics' Interest & Investment Income (Yearly) stood at $6.1 million in 2022, then spiked by 178.22% to $16.9 million in 2023, then increased by 9.02% to $18.4 million in 2024.